Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. - Blonde,L.; Klein,EJ.; Han,J. (Diabetes Obes Metab, 2006)